Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens.
Serological typing of P. aeruginosa is the most simple and reliable procedure recommended for "in-house" investigations and for studies of suspected outbreaks of infection by this microorganism. It is also a useful procedure in order to know serotype prevalence in a definite geographical area and to obtain indications about the more appropriate composition of polyvalent anti-Pseudomonas vaccines. In the present report, we describe the relatively high frequency of isolation of serogroup 12 from patients in Palermo, Italy. Serogroup 12 is very rare in north-Europe and in the USA, and, as a consequence, it is not included in some vaccine preparations. In Palermo, strains belonging to this serogroup, resistant to a large number of antibiotics, were on the contrary isolated, during more than six years, in different hospitals and from three out-patients. In a Burns Unit, they were in particular responsible for extensive and life-threatening outbreaks.
D001428:Bacterial Vaccines; D002053:Burn Units; D002056:Burns / Q000382:microbiology; D006801:Humans; D007558:Italy; D011552:Pseudomonas Infections / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D054406:Pseudomonas Vaccines; D011550:Pseudomonas aeruginosa / Q000145:classification* / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000382:microbiology; D012703:Serotyping; D013530:Surgical Wound Infection / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology; D017778:Vaccines, Combined
D001428:Bacterial Vaccines; D054406:Pseudomonas Vaccines; D017778:Vaccines, Combined; C039987:polyvalent pseudomonas vaccine